Who owns Rimadyl?
Rimadyl is owned by Zoetis (the United States, NYSE: ZTS).[1]
Evidence: Zoetis Inc. Annual Report on Form 10-K filed 2026-02-12, SEC EDGAR, 12 February 2026. Verified from filings; last checked .
Key facts
- Current owner
- Zoetis Inc. verified
- Owner HQ
- 🇺🇸 United States, Parsippany, New Jersey
- Origin
- 🇺🇸 United States
- Category
- Pet & animal care › Pet supplies & services › Veterinary services
- Parent ticker
- NYSE: ZTS
- Trademark registrant
- ZOETIS SERVICES LLC (USPTO)
- Last verified
- · 2 sources
About Rimadyl
Rimadyl is a non-steroidal anti-inflammatory for dogs, used to relieve the pain and inflammation of osteoarthritis and to control postoperative pain after soft tissue and orthopaedic surgery. It is the conventional treatment that Zoetis's antibody therapies Librela and Solensia were developed alongside rather than to replace, and it remains a product line accounting for about one per cent or more of company revenue.
What Zoetis's annual report says about Rimadyl
Sentences about Rimadyl from Zoetis's latest annual filing[1], copied word for word.
For example, several companies have launched generic versions of our Rimadyl chewable and Draxxin products.
In the years since the start of generic and other competition, sales of our Rimadyl chewable and Draxxin products have declined in the U.S., the largest market for these products, by 39% and 66%, respectively.
How often Zoetis names Rimadyl in its annual report
A plain count of the times the name appears in the text of each annual report, not counting the start of a sentence. A brand that an owner writes about more is usually one it treats as central.
Trademark record for Rimadyl
The USPTO record for the Rimadyl mark lists ZOETIS SERVICES LLC as the owner of record (serial number 73220584). That name matches the owner named above.[2]
Ownership timeline of Rimadyl
Where Rimadyl sits in Zoetis
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Zoetis ownership tree →
See the full Zoetis brand portfolio (17) →
Other brands owned by Zoetis
Zoetis controls 17 brands on Brandtree, 17 of them in pet & animal care.
Also in pet & animal care
Other brands in veterinary services, and who owns them
Zoetis has more brands in veterinary services on Brandtree than any other owner: 17 of 45.
About the owner: Zoetis
Zoetis is a publicly listed company headquartered in Parsippany, New Jersey, United States, founded in 2012. Brandtree records 17 brands under its control, and it is listed as NYSE: ZTS.
Zoetis is the largest animal health company in the world by revenue, selling medicines, vaccines and diagnostics for pets and livestock. It was incorporated in Delaware in July 2012 out of what had been a business unit of Pfizer, and it markets directly in about 45 countries while selling in more than 100. Companion animals now dominate: its two biggest lines, the Simparica parasiticides and the Apoquel dermatology range, were 16 and 12 per cent of 2025 revenue, and it left the medicated feed additive business entirely in 2024.
🇺🇸 Rimadyl and other American brands
Brandtree records a controlling owner for 2,399 brands that began in the United States. 461 of them (19%) are now controlled by a company headquartered in another country; Rimadyl is not one of them.
- 4health — Tractor Supply 🇺🇸
- Advantage — Elanco 🇺🇸
- American Journey — Chewy 🇺🇸
- Aqueon — Central Garden & Pet 🇺🇸
- Aureomycin — Phibro 🇺🇸
- BARK — BARK 🇺🇸
Frequently asked questions
Who is the parent company of Rimadyl?
The parent company of Rimadyl is Zoetis, a publicly listed company headquartered in the United States.
Is Rimadyl American?
Yes. Rimadyl originated in the United States and its owner, Zoetis, is also headquartered in the United States.
Is Rimadyl still owned by Zoetis?
Yes. As of 9 October 2026, Rimadyl is still owned by Zoetis. The ownership record was last checked against primary sources on that date.
Sources (2) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Zoetis Inc. Annual Report on Form 10-K filed 2026-02-12 — SEC EDGAR, SEC Form 10-K, published 12 February 2026; retrieved 25 September 2026.
- [2] USPTO: RIMADYL, serial 73220584 — United States Patent and Trademark Office, Trademark registry; retrieved 27 September 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.